CN Patent

CN112752570A — 生物可利用口服剂型

Assigned to PTC Therapeutics Inc · Expires 2021-05-04 · 5y expired

What this patent protects

本发明涉及具有增加的剂量负载和改进的溶解而较少受到食物影响的生物可利用药物组合物。

USPTO Abstract

本发明涉及具有增加的剂量负载和改进的溶解而较少受到食物影响的生物可利用药物组合物。

Drugs covered by this patent

alectinib-hydrochloride (ALECTINIB HYDROCHLORIDE)

Patent Metadata

Patent number: CN112752570A
Jurisdiction: CN
Classification: —
Expires: 2021-05-04
Drug substance claim: No
Drug product claim: No
Assignee: PTC Therapeutics Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.